Find a Doctor

Anne Floquet

Institut Bergonié


Anne Floquet is in Bordeaux, France. They have been an author on 83 peer reviewed articles and participated in 7 clinical trials in the past 15 years. Dr. Floquet's top three areas of expertise are Endometrial Stromal Sarcoma, Ovarian Cancer, and Leiomyosarcoma.


Bordeaux, FR

Latest Research

Latest Advance
  • Condition: Advanced Ovarian Cancer
  • Journal: Gynecologic oncology
  • Treatment Used: Pazopanib
  • Number of Patients: 940
  • Published —
In this study, researchers evaluated the outcomes of pazopanib for the maintenance of advanced ovarian cancer after first-line chemotherapy.
Latest Advance
  • Condition: Localized High Grade Endometrial Stromal Sarcoma and Localized Undifferentiated Uterine Sarcoma
  • Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • Treatment Used: Surgical Resection and Adjuvant Radiotherapy and Chemotherapy
  • Number of Patients: 39
  • Published —
This study analyzed patients with localized high grade endometrial stromal sarcoma and undifferentiated uterine sarcomas (stages I-III) and their treatments.
Latest Advance
  • Condition: Newly Diagnosed Advanced Ovarian Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: maintenance Olaparib
  • Number of Patients: 260
  • Published —
The purpose of the study was to evaluate the effectiveness of olaparib as maintenance therapy in newly diagnosed advanced ovarian cancer.
Latest Advance
  • Condition: Metastatic progesterone receptor-expressing cancers
  • Journal: PloS one
  • Treatment Used: Onapristone
  • Number of Patients: 52
  • Published —
This study evaluated the effects of onapristone in patients with metastatic progesterone receptor-expressing cancers.

Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Study Type: Other
  • Participants: 20
  • Start Date: September 2019
MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii
Clinical Trial
Diagnostic Test
  • Status: Recruiting
  • Study Type: Diagnostic Test
  • Participants: 480
  • Start Date: May 7, 2018
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy


Bordeaux, FR


Contact them to find out if they accept your insurance plan.